DE69730723D1 - Medizinische aerosolformulierungen von formoterol - Google Patents

Medizinische aerosolformulierungen von formoterol

Info

Publication number
DE69730723D1
DE69730723D1 DE69730723T DE69730723T DE69730723D1 DE 69730723 D1 DE69730723 D1 DE 69730723D1 DE 69730723 T DE69730723 T DE 69730723T DE 69730723 T DE69730723 T DE 69730723T DE 69730723 D1 DE69730723 D1 DE 69730723D1
Authority
DE
Germany
Prior art keywords
medical aerosol
formoterol formulations
formoterol
formulations
aerosol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69730723T
Other languages
English (en)
Other versions
DE69730723T2 (de
Inventor
J Oliver
G Paling
A Jinks
K Jaiswal
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
3M Co
Original Assignee
Minnesota Mining and Manufacturing Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10795182&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69730723(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Minnesota Mining and Manufacturing Co filed Critical Minnesota Mining and Manufacturing Co
Application granted granted Critical
Publication of DE69730723D1 publication Critical patent/DE69730723D1/de
Publication of DE69730723T2 publication Critical patent/DE69730723T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A61K9/124—Aerosols; Foams characterised by the propellant

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE69730723T 1996-06-11 1997-06-02 Medizinische aerosolformulierungen von formoterol Expired - Lifetime DE69730723T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9612297.3A GB9612297D0 (en) 1996-06-11 1996-06-11 Medicinal aerosol formulations
GB9612297 1996-06-11
PCT/US1997/009471 WO1997047286A1 (en) 1996-06-11 1997-06-02 Medicinal aerosol formulations of formoterol

Publications (2)

Publication Number Publication Date
DE69730723D1 true DE69730723D1 (de) 2004-10-21
DE69730723T2 DE69730723T2 (de) 2005-10-06

Family

ID=10795182

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69730723T Expired - Lifetime DE69730723T2 (de) 1996-06-11 1997-06-02 Medizinische aerosolformulierungen von formoterol

Country Status (16)

Country Link
EP (2) EP0934057B1 (de)
JP (1) JP5000793B2 (de)
AR (1) AR009231A1 (de)
AT (1) ATE275940T1 (de)
AU (1) AU726382B2 (de)
CA (1) CA2257841C (de)
DE (1) DE69730723T2 (de)
DK (1) DK0934057T3 (de)
ES (1) ES2229366T3 (de)
GB (1) GB9612297D0 (de)
ID (1) ID19520A (de)
NO (1) NO320403B1 (de)
NZ (1) NZ333202A (de)
PT (1) PT934057E (de)
WO (1) WO1997047286A1 (de)
ZA (1) ZA974546B (de)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6054488A (en) * 1996-06-11 2000-04-25 3M Innovative Properties Company Medicinal aerosol formulations of formoterol
GB9616237D0 (en) 1996-08-01 1996-09-11 Norton Healthcare Ltd Aerosol formulations
US20010031244A1 (en) 1997-06-13 2001-10-18 Chiesi Farmaceutici S.P.A. Pharmaceutical aerosol composition
US6423298B2 (en) * 1998-06-18 2002-07-23 Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceutical formulations for aerosols with two or more active substances
US6451285B2 (en) 1998-06-19 2002-09-17 Baker Norton Pharmaceuticals, Inc. Suspension aerosol formulations containing formoterol fumarate and a fluoroalkane propellant
ID29605A (id) * 1998-10-17 2001-09-06 Boehringer Ingelheim Pharma Konsentrat bahan aktif dengan formoterol, yang sesuai untuk penyimpanan
DE19847969A1 (de) * 1998-10-17 2000-04-20 Boehringer Ingelheim Pharma Lagerfähig flüssige Formulierung mit Formoterol
IT1303788B1 (it) * 1998-11-25 2001-02-23 Chiesi Farma Spa Formulazioni di aerosol medicinali.
DZ2947A1 (fr) 1998-11-25 2004-03-15 Chiesi Farma Spa Inhalateur à compteur de dose sous pression.
US6290930B1 (en) 1998-12-18 2001-09-18 Baker Norton Pharmaceuticals, Inc. Pharmaceutical solution aerosol formulations containing fluoroalkanes and budesonide
US6004537A (en) * 1998-12-18 1999-12-21 Baker Norton Pharmaceuticals, Inc. Pharmaceutical solution aerosol formulations containing fluoroalkanes, budesonide and formoterol
IT1313553B1 (it) 1999-07-23 2002-09-09 Chiesi Farma Spa Formulazioni ottimizzate costituite da soluzioni di steroidi dasomministrare per inalazione.
IT1317846B1 (it) 2000-02-22 2003-07-15 Chiesi Farma Spa Formulazioni contenenti un farmaco anticolinergico per il trattamentodella broncopneumopatia cronica ostruttiva.
SK286694B6 (sk) * 2000-05-22 2009-03-05 Chiesi Farmaceutici S.P.A. Aerosólový farmaceutický prostriedok
SE0004750D0 (sv) 2000-12-19 2000-12-19 Astrazeneca Ab Novel formulation
US20030055026A1 (en) 2001-04-17 2003-03-20 Dey L.P. Formoterol/steroid bronchodilating compositions and methods of use thereof
ES2222294T3 (es) 2001-07-02 2005-02-01 Chiesi Farmaceutici S.P.A. Formulacion optimizada de tobramicina para administracion en forma de aerosol.
TWI324934B (en) * 2001-08-28 2010-05-21 Schering Corp Pharmaceutical compositions for the treatment of asthma
GB0207906D0 (en) 2002-04-05 2002-05-15 3M Innovative Properties Co Formoterol and mometasone aerosol formulations
GB0207899D0 (en) * 2002-04-05 2002-05-15 3M Innovative Properties Co Formoterol and cielesonide aerosol formulations
JP4679901B2 (ja) 2002-08-27 2011-05-11 シェーリング コーポレイション 定量吸入処方物を産生するためのプロセス
EP1635845A1 (de) * 2003-06-13 2006-03-22 ALTANA Pharma AG Kombination aus formoterol und ciclesonid
TWI359675B (en) 2003-07-10 2012-03-11 Dey L P Bronchodilating β-agonist compositions
CN1870976A (zh) * 2003-10-20 2006-11-29 先灵公司 药物组合物
EP1925293A3 (de) * 2003-10-20 2010-01-13 Schering Corporation Pharmazeutische Aerosol-Zusammensetzungen
EP1595531A1 (de) 2004-05-13 2005-11-16 CHIESI FARMACEUTICI S.p.A. Stabile Arzneimittellösung für Druckdosierinhalatoren
AU2007313077B2 (en) * 2006-10-17 2011-06-02 Neothetics, Inc. Methods, compositions, and formulations for the treatment of thyroid eye disease
RU2580315C3 (ru) 2009-05-29 2021-06-18 Перл Терапьютикс, Инк. Композиции для респираторной доставки активных веществ и связанные с ними способы и системы
US8815258B2 (en) 2009-05-29 2014-08-26 Pearl Therapeutics, Inc. Compositions, methods and systems for respiratory delivery of two or more active agents
CN103919785B (zh) * 2009-10-02 2016-08-24 奇斯药制品公司 福莫特罗和二丙酸倍氯米松的药用气雾制剂
SG11201507286QA (en) 2013-03-15 2015-10-29 Pearl Therapeutics Inc Methods and systems for conditioning of particulate crystalline materials

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2050905A1 (en) * 1989-02-23 1990-08-24 George R. Felt Therapeutic aerosol formulations
IL97065A (en) * 1990-02-02 1994-01-25 Fisons Plc Repellent preparations for aerosol
GB9024365D0 (en) * 1990-11-09 1991-01-02 Glaxo Group Ltd Medicaments
EP0504112A3 (en) * 1991-03-14 1993-04-21 Ciba-Geigy Ag Pharmaceutical aerosol formulations
EP0518601A1 (de) * 1991-06-10 1992-12-16 Schering Corporation Nichtchlorfluorkohlenstoff-Aerosolformulierungen
ATE246497T1 (de) * 1991-06-10 2003-08-15 Schering Corp Fluorchlorkohlenwasserstoffreie aerosolformulierungen
IL104068A (en) * 1991-12-12 1998-10-30 Glaxo Group Ltd Pharmaceutical preparations in a spray without surfactant containing 1, 1, 1, 2 tetrafluoroethane or 1,1,2,3,3 petafluor N propane as propellant
EP0616525B1 (de) * 1991-12-12 1995-09-27 Glaxo Group Limited Pharmazeutische Aerosolformulierung
ATE204743T1 (de) * 1991-12-18 2001-09-15 Minnesota Mining & Mfg Aerosolzusammensetzungen für arzneimittelsuspensionen
GB9207400D0 (en) * 1992-04-02 1992-05-13 Smithkline Beecham Plc Novel use
US5354934A (en) * 1993-02-04 1994-10-11 Amgen Inc. Pulmonary administration of erythropoietin
GB9425160D0 (en) * 1994-12-10 1995-02-08 Glaxo Group Ltd Medicaments
GB9426252D0 (en) * 1994-12-24 1995-02-22 Glaxo Group Ltd Pharmaceutical composition

Also Published As

Publication number Publication date
AU726382B2 (en) 2000-11-02
AU3373997A (en) 1998-01-07
WO1997047286A1 (en) 1997-12-18
JP5000793B2 (ja) 2012-08-15
CA2257841C (en) 2008-05-20
NO985720D0 (no) 1998-12-07
PT934057E (pt) 2004-12-31
EP0934057B1 (de) 2004-09-15
ID19520A (id) 1998-07-16
GB9612297D0 (en) 1996-08-14
ATE275940T1 (de) 2004-10-15
NO320403B1 (no) 2005-11-28
ZA974546B (en) 1998-11-23
CA2257841A1 (en) 1997-12-18
DE69730723T2 (de) 2005-10-06
NO985720L (no) 1999-02-11
AR009231A1 (es) 2000-04-12
DK0934057T3 (da) 2005-01-24
EP0934057A1 (de) 1999-08-11
ES2229366T3 (es) 2005-04-16
NZ333202A (en) 2000-06-23
JP2000513340A (ja) 2000-10-10
EP1400239A1 (de) 2004-03-24

Similar Documents

Publication Publication Date Title
DE69730723D1 (de) Medizinische aerosolformulierungen von formoterol
ATE236617T1 (de) Aerosol-arzneiformulierungen
DE69727329D1 (de) Medizinische Elektrode
DE69503467D1 (de) Temporäre medizinische elektrode
DE69021387D1 (de) Medizinische aerosolformulierungen.
DE69735497D1 (de) Medizinische aerosolformulierungen enthaltend budesonide
DE69738755D1 (de) Sofort auflösbare medizinische zusammenstellung
DE68924540D1 (de) Medizinische Aerosolformulierungen.
ATE176383T1 (de) Dermal applizierbare formulierungen von parasitiziden
DE59401563D1 (de) Medizinische Zange
DE69709366D1 (de) Medizinische klebende zusammensetzung und verpackung
NO944526D0 (no) Medisinsk aerosolformulering
DE69826683D1 (de) Therapeutische zusammensetzungen, enthaltend amlopidin und atorvastatin
IT1293803B1 (it) Formulazioni di aerosol medicinali
FR2747926B1 (fr) Inhalateurs ameliores
IS4921A (is) Lækningatæki
DE59707298D1 (de) Desodorierende zubereitungen
ID18832A (id) Komposisi insektisida
ATE237934T1 (de) Insektizide und mitizide zusammensetzungen
BR9708248A (pt) Benzotiofenos formulações contendo os mesmos e metódos
BR9707657A (pt) Benzotiofenos formulações contendo os mesmos e métodos
ITMI941169A0 (it) Formulazioni farmaceutiche
ATE298576T1 (de) Arzneizubereitungen
ATE237309T1 (de) Arzneizubereitungen
PT944313E (pt) Composicoes insecticidas e miticidas

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8310 Action for declaration of annulment
8313 Request for invalidation rejected/withdrawn